Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) shares shot up 5.3% during mid-day trading on Thursday . The company traded as high as $3.40 and last traded at $3.37. 776,875 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 2,204,204 shares. The stock had previously closed at […]
Zacks Research Research Analysts Raise Earnings Estimates for Allogene Therapeutics, Inc. (NASDAQ:ALLO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.88 and last traded at $3.03, with a volume of 486164 shares changing hands. The stock had previously closed at $3.08. Analysts Set New Price Targets A number of brokerages […]
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eight have assigned a buy recommendation to the company. […]
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price cut by JPMorgan Chase & Co. from $11.00 to $9.00 in a research report sent to investors on Monday morning, Marketbeat.com reports. They currently have an overweight rating on the stock. ALLO has been the subject of a number of other research reports. Oppenheimer reaffirmed […]